Division of Infectious Diseases, William Osler Health System, Brampton, Canada.
Clin Infect Dis. 2012 Dec;55(11):e109-17. doi: 10.1093/cid/cis737. Epub 2012 Sep 20.
New Delhi metallo-ß-lactamase (NDM) has emerged worldwide in clinically relevant gram-negative bacteria. We report an outbreak of NDM-producing Klebsiella pneumoniae in patients with no prior travel history to endemic regions.
Five NDM-1-producing K. pneumoniae colonizing and/or clinically infecting patients in a community tertiary hospital were detected between October and November 2011. NDM-1-producing Enterobacteriaceae (K. pneumoniae and Escherichia coli) were clinically and epidemiologically characterized, including susceptibility profiles, molecular typing, and molecular characterization of plasmids and resistant determinants.
Five patients were identified carrying NDM-1-producing K. pneumoniae, all of them epidemiologically linked with each other. K. pneumoniae were confirmed to belong to the same clone, exhibiting multidrug-resistant phenotypes. One patient was positive for NDM-1-producing E. coli in blood and E. coli and K. pneumoniae in rectal specimens, both containing the same bla(NDM) plasmid, suggesting horizontal transfer between species in the patient. No environmental sources of these strains were found. Detection of positive isolates directly from rectal specimens allowed the rapid identification and isolation of colonized patients.
We report a NDM-1-producing K. pneumoniae outbreak in Ontario, Canada. Implementation of standard infection control practices, including active screening was able to contain the spread of this organism in the hospital setting. Of concern is the potential loss of a travel history to identify patients that are at high risk of being colonized or infected with this organism and the lack of an accurate, cost-effective test that can be implemented in the hospital setting to identify these multidrug-resistant organisms.
新德里金属-β-内酰胺酶(NDM)已在临床上相关的革兰氏阴性细菌中在全球范围内出现。我们报告了在没有前往流行地区旅行史的患者中出现产 NDM 的肺炎克雷伯菌的爆发。
2011 年 10 月至 11 月期间,在一家社区三级医院中发现了 5 例定植和/或临床感染产 NDM-1 肺炎克雷伯菌的患者。对产 NDM-1 的肠杆菌科(肺炎克雷伯菌和大肠杆菌)进行了临床和流行病学特征分析,包括药敏谱、分子分型以及质粒和耐药决定因素的分子特征。
鉴定出 5 例携带产 NDM-1 肺炎克雷伯菌的患者,他们均具有流行病学关联。肺炎克雷伯菌被证实属于同一克隆,表现出多药耐药表型。1 例患者的血液中存在产 NDM-1 的大肠杆菌,直肠标本中存在大肠杆菌和肺炎克雷伯菌,均含有相同的 bla(NDM)质粒,提示该患者体内的种间水平转移。未发现这些菌株的环境来源。直接从直肠标本中检测到阳性分离株有助于快速识别和隔离定植患者。
我们报告了加拿大安大略省产 NDM-1 肺炎克雷伯菌的爆发。实施标准感染控制措施,包括主动筛查,能够控制该病原体在医院环境中的传播。令人担忧的是,缺乏旅行史来识别处于定植或感染该病原体高风险的患者,以及缺乏能够在医院环境中实施的准确、具有成本效益的检测方法来识别这些多药耐药生物体。